September 2, 2011
From KEI staff review of Wikileaks cables (/wikileaks)
This is a US Department of State cable reporting on the WIPO SCCR 17 meeting, which took place November 3-7, 2008. This was the first meeting focusing primarily on copyrigh limitations and exceptions, and also, the meeting where the World Blind Union first presented its proposal for a treaty.
Among the observations reported in the cable:
September 2, 2011
From KEI staff review of Wikileaks cables (/wikileaks)
This cable reports on a meeting between U.S. and European diplomats and executives from 13 pharmaceutical companies (7 US, 2 UK, 2 Swiss, 1 German and 1 French).
The companies complained about “unstable pricing policies, GOP reimbursement delays, capricious and opaque revenue caps, and lax enforcement of patent rights.
September 3, 2011 From KEI staff review of Wikileaks cables (/wikileaks) On May 14, 2008, The US Embassy in Warsaw sent a cable that discussed additions to the list of pharmaceutical products reimbursed by the government. A few highlights from… Continue Reading
Salon has an article today with this title: The seduction of Howard Dean, by Justin Elliot.
Two cables recently disclosed by Wikileaks illustrate the degree to which the Obama Administration was monitoring the EU review of the Oracle acquisition of Sun, and leaning on the European Union to permit Oracle to acquire MySQL and other “open source” assets controlled by Sun.
Both cables were signed by Ambassador Christopher W. Murray, who served as Deputy Chief of Mission and Chargé d’Affaires at the United States Mission to the European Union, in Brussels, Belgium, from 2007 to 2010.
The following are 2,446 cables from Wikileaks, that mention the search term: “pharmaceutical.” The search was conducted on August 29, 2011. This is an average of 23 cables per week, for the period. The cables are organized by dates.
August 29, 2011
From KEI staff review of Wikileaks cables (/wikileaks)
The following are the cables identified in an August 29, 2011 search of the wikileaks cables, from http://cablesearch.net, using the search terms data exclusivity and pharmaceutical. This search identified 240 cables. Some 40 countries are mentioned in the cables. More than half of the cables involve 5 countries: Turkey (76), Taiwan (21), El Salvador (11), Honduras (11) and Tunisia (10).
These are some notes on some of the new Wikileaks cables. (Much more at /wikileaks)
May 18, 2009. Pfizer meets asks US embassy to intervene in Philippines debate over drug prices. Embassy agrees to tell Philippines government that “imposition of price controls . . . would be unacceptable..”
http://wikileaks.org/cable/2009/05/09MANILA1060.html
Subject: Health Department Patent Remedies to Cut Drug Prices
¶1. (SBU) Summary: The Philippine Department of Health is close to
Continue Reading
August 28, 2011
From KEI staff review of Wikileaks cables (/wikileaks)
Among the many new cables released by Wikileaks is this gem, a detailed account of the U.S. government pressure on the Guatemala legislature to shape legislation on pharmaceutical test data IPR.
http://wikileaks.org/cable/2005/03/05GUATEMALA659.html
C O N F I D E N T I A L SECTION 01 OF 05 GUATEMALA 000659SIPDIS
E.O. 12958: DECL: 03/11/2010
TAGS: ETRD KIPR PGOV PREL GT
Continue Reading
As part of the American University hosted Global Congress on Intellectual Property and the public Interest, I participated in a panel on the positive agenda for intellectual property. These are notes from my talk.
Presentation by Manon Anne Ress, Knowledge Ecology International
August 26, 2011, at American University in Washington, DC